| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 34.427 | 63.763 | 84.285 | 194.014 | 325.005 | 416.924 | 498.461 | 562.733 |
| Total Income - EUR | - | - | 34.427 | 63.763 | 84.285 | 203.937 | 325.371 | 416.954 | 498.533 | 812.755 |
| Total Expenses - EUR | - | - | 5.820 | 18.029 | 31.515 | 118.223 | 188.501 | 239.995 | 319.582 | 704.353 |
| Gross Profit/Loss - EUR | - | - | 28.607 | 45.734 | 52.770 | 85.714 | 136.870 | 176.960 | 178.951 | 108.402 |
| Net Profit/Loss - EUR | - | - | 27.456 | 43.821 | 50.241 | 83.812 | 134.007 | 173.416 | 174.710 | 95.954 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 3 | 2 | 3 |
Check the financial reports for the company - Gyneconseil Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 19.840 | 16.026 | 54.455 | 47.151 | 104.518 | 368.269 | 396.807 | 65.481 |
| Current Assets | - | - | 22.710 | 42.568 | 53.454 | 118.360 | 145.865 | 77.915 | 95.588 | 388.561 |
| Inventories | - | - | 0 | 0 | 1.638 | 0 | 24.236 | 3.119 | 7.331 | 0 |
| Receivables | - | - | 0 | 0 | 2.208 | 2.460 | 3.763 | 4.426 | 12.466 | 268.065 |
| Cash | - | - | 22.710 | 42.568 | 49.607 | 115.900 | 36.653 | 70.369 | 75.791 | 120.496 |
| Shareholders Funds | - | - | 27.500 | 50.931 | 74.069 | 139.286 | 214.027 | 279.671 | 362.330 | 322.294 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 15.050 | 7.663 | 33.840 | 26.225 | 36.356 | 166.512 | 134.389 | 131.748 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gyneconseil Srl